Structure Therapeutics has named Blai Coll as its chief medical officer, succeeding Mark Bach as part of a planned succession, effective Wednesday. Dr. Coll since 2022 has served as vice president ...

31R), a specialty life sciences company focused on the research and development of therapeutics for infectious diseases and medical countermeasures, announced today its strategic focus on ...

Huntsville, Alabama--(Newsfile Corp. - September 16, 2024) - Kalm Therapeutics (Kalm Tx) is pleased to announce the appointment of Dr. Tomoko Maeda-Chubachi, M.D., Ph.D., as our Chief Medical Officer.

TORONTO, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE ...

TORONTO, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life ...

The BM-1 bench top vibration isolation platform is our highest capacity bench top isolator. A cost effective product for weight loads up to 1000 lb. and 1/2 Hz performance vertical and horizontal.

Nirvana, a Lower Manhattan-based medical billing platform, raised $24 million in a Series A fundraising round, the company announced last week. The company uses machine learning models to predict ...

Traumatic brain injury (TBI) results in close to 70,000 deaths in the United States every year, and it is the cause of long-term physical, cognitive and mental disability in 5 million Americans. But ...

Bicycle Therapeutics (BCYC – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst ...

Structure Therapeutics (Nasdaq: GPCR), a specialist in small molecule ... The firm said it was looking to boost its clinical development operations by promoting Blai Coll to chief medical officer and ...

MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), and Kamau Therapeutics ... MaxCyte and the use of their proven non-viral platform, our goal is to treat or cure a range of serious genetic diseases with unmet ...